378 related articles for article (PubMed ID: 16353949)
41. Cardiovascular and temperature adverse actions of stimulants.
Docherty JR; Alsufyani HA
Br J Pharmacol; 2021 Jul; 178(13):2551-2568. PubMed ID: 33786822
[TBL] [Abstract][Full Text] [Related]
42. Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts.
Jayanthi LD; Vargas G; DeFelice LJ
Br J Pharmacol; 2002 Apr; 135(8):1927-34. PubMed ID: 11959795
[TBL] [Abstract][Full Text] [Related]
43. [The role of glial monoamine transporters in the central nervous system].
Inazu M; Takeda H; Matsumiya T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
[TBL] [Abstract][Full Text] [Related]
44. Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters.
Mulvihill KG
Neurochem Int; 2019 Jan; 122():94-105. PubMed ID: 30465801
[TBL] [Abstract][Full Text] [Related]
45. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
Lorenzo-Sanz G; Sánchez-Herranz A
Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
[TBL] [Abstract][Full Text] [Related]
46. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
47. The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.
Timple JM; Magalhães LG; Souza Rezende KC; Pereira AC; Cunha WR; Andrade e Silva ML; Mortensen OV; Fontana AC
J Nat Prod; 2013 Oct; 76(10):1889-95. PubMed ID: 24112084
[TBL] [Abstract][Full Text] [Related]
48. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
49. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2.
Noskova V; Bottalico B; Olsson H; Ehinger A; Pilka R; Casslén B; Hansson SR
Mol Hum Reprod; 2006 Aug; 12(8):483-9. PubMed ID: 16567367
[TBL] [Abstract][Full Text] [Related]
50. Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD.
Stanford SC
Neuropharmacology; 2014 Dec; 87():9-18. PubMed ID: 24727210
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
Schmitt KC; Reith ME
Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
[TBL] [Abstract][Full Text] [Related]
52. Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor.
Haleem DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():170-80. PubMed ID: 23906987
[TBL] [Abstract][Full Text] [Related]
53. Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt.
Zhao G; Qin GW; Wang J; Chu WJ; Guo LH
Neurochem Int; 2010 Jan; 56(1):168-76. PubMed ID: 19815045
[TBL] [Abstract][Full Text] [Related]
54. SLC6 neurotransmitter transporters: structure, function, and regulation.
Kristensen AS; Andersen J; Jørgensen TN; Sørensen L; Eriksen J; Loland CJ; Strømgaard K; Gether U
Pharmacol Rev; 2011 Sep; 63(3):585-640. PubMed ID: 21752877
[TBL] [Abstract][Full Text] [Related]
55. Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.
Haenisch B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jan; 381(1):33-9. PubMed ID: 20012264
[TBL] [Abstract][Full Text] [Related]
56. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.
Greer CL; Grygoruk A; Patton DE; Ley B; Romero-Calderon R; Chang HY; Houshyar R; Bainton RJ; Diantonio A; Krantz DE
J Neurobiol; 2005 Sep; 64(3):239-58. PubMed ID: 15849736
[TBL] [Abstract][Full Text] [Related]
57. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
Haenisch B; Bönisch H
Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
[TBL] [Abstract][Full Text] [Related]
58. Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.
Liu JJ; Hezghia A; Shaikh SR; Cenido JF; Stark RE; Mann JJ; Sublette ME
Neuropsychopharmacology; 2018 Oct; 43(11):2165-2179. PubMed ID: 30022062
[TBL] [Abstract][Full Text] [Related]
59. A Conserved Intramolecular Ion-Pair Plays a Critical but Divergent Role in Regulation of Dimerization and Transport Function among the Monoamine Transporters.
Chen S; Huang X; Zhang X; Li C; Zhang YW
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612840
[TBL] [Abstract][Full Text] [Related]
60. New views of biogenic amine transporter function: implications for neuropsychopharmacology.
Frazer A; Gerhardt GA; Daws LC
Int J Neuropsychopharmacol; 1999 Dec; 2(4):305-320. PubMed ID: 11285147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
